Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Borqs Technologies, Inc.BRQS · Entity 8297 | EVP & President of Inter. Bus | August 18, 2017 | August 22, 2017 |
| DNA X, Inc.SONM · Entity 8261 | Director | July 18, 2025 | October 15, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Borqs Technologies, Inc.
Report date August 18, 2017 · Filed August 22, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $4.86 · Expires 2024-11-20 | Direct | 94,468 |
Reported balance
After 2017-08-18 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2017-08-18 · Grant · Acquired 94,468 · Balance 94,468 F1: Received in exchange for a stock option to acquire 1,000,000 ordinary shares of Borqs International Holding Corp. ("Borqs") in connection with the merger of Borqs into Pacific Special Acquisition Corp. (the "Merger"). The options became vested as to 1/4 of the total grant on November 21, 2015, and an additional 1/48 of the total grant vests each month thereafter. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $4.86 · Expires 2025-02-06 | Direct | 47,234 |
Reported balance
After 2017-08-18 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2017-08-18 · Grant · Acquired 47,234 · Balance 47,234 F2: Received in the Merger in exchange for a stock option to acquire 500,000 ordinary shares of Borqs. The options became vested as to 1/4 of the total grant on February 7, 2016, and an additional 1/48 of the total grant vests each month thereafter. |
Filing footnotes · ownership attribution and instrument terms
F1: Received in exchange for a stock option to acquire 1,000,000 ordinary shares of Borqs International Holding Corp. ("Borqs") in connection with the merger of Borqs into Pacific Special Acquisition Corp. (the "Merger"). The options became vested as to 1/4 of the total grant on November 21, 2015, and an additional 1/48 of the total grant vests each month thereafter.
F2: Received in the Merger in exchange for a stock option to acquire 500,000 ordinary shares of Borqs. The options became vested as to 1/4 of the total grant on February 7, 2016, and an additional 1/48 of the total grant vests each month thereafter.
DNA X, Inc.
Report date July 18, 2025 · Filed October 15, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 723 |
Reported balance
Holding disclosure · report date 2025-07-18 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 723 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 18, 2017 Filed Aug 22, 2017 16:59 UTC | Borqs Technologies, Inc. BRQS · Entity 8297 | GrantStock Option (Right to Buy) · Derivative | 47,234 | Not disclosed Strike: $4.86 | Not disclosed |
DisclosureSEC source: 0001213900-17-009100 · f4081817thangadurai_borqs.xml · derivative · entry 2 Thangadurai George · CIK 0001714709 · EVP & President of Inter. Bus 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,234 Underlying: Ordinary Shares · 47,234 shares Expires 2025-02-06 F2 · price: Received in the Merger in exchange for a stock option to acquire 500,000 ordinary shares of Borqs. The options became vested as to 1/4 of the total grant on February 7, 2016, and an additional 1/48 of the total grant vests each month thereafter. F2 · derivative.exercise_date: Received in the Merger in exchange for a stock option to acquire 500,000 ordinary shares of Borqs. The options became vested as to 1/4 of the total grant on February 7, 2016, and an additional 1/48 of the total grant vests each month thereafter. Read SEC document |
| August 18, 2017 Filed Aug 22, 2017 16:59 UTC | Borqs Technologies, Inc. BRQS · Entity 8297 | GrantStock Option (Right to Buy) · Derivative | 94,468 | Not disclosed Strike: $4.86 | Not disclosed |
DisclosureSEC source: 0001213900-17-009100 · f4081817thangadurai_borqs.xml · derivative · entry 1 Thangadurai George · CIK 0001714709 · EVP & President of Inter. Bus 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,468 Underlying: Ordinary Shares · 94,468 shares Expires 2024-11-20 F1 · price: Received in exchange for a stock option to acquire 1,000,000 ordinary shares of Borqs International Holding Corp. ("Borqs") in connection with the merger of Borqs into Pacific Special Acquisition Corp. (the "Merger"). The options became vested as to 1/4 of the total grant on November 21, 2015, and an additional 1/48 of the total grant vests each month thereafter. F1 · derivative.exercise_date: Received in exchange for a stock option to acquire 1,000,000 ordinary shares of Borqs International Holding Corp. ("Borqs") in connection with the merger of Borqs into Pacific Special Acquisition Corp. (the "Merger"). The options became vested as to 1/4 of the total grant on November 21, 2015, and an additional 1/48 of the total grant vests each month thereafter. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.